by
Patricia Mayville-Cox, The Cancer Blog
Filed under: Research According to a study by the Tufts Center for the Study of Drug Development, only eight percent of cancer drugs that entered clinical development and testing in humans made it through to final approval. In comparison, during the same time period, 1993-1997, the U.S. has an approval rate...
add a comment
|
Sep 09, 2007